Therefore, the use of therapeutic agents that modulate SHIP-1 expression will provide more insight into the possible role of SHIP-1 as a tumor suppressor in solid tumors such as pancreatic cancer. The gene discussed is INPP5D; the disease is pancreatic neoplasm.